Grontvedt Biotech

Grøntvedt Biotech is a Norwegian life sciences company specializing in the development and production of high-quality marine ingredients derived from pelagic fish. As a subsidiary of the Grøntvedt Group, the company utilizes a circular economy model to process fresh raw materials into potent omega-3 oils and proteins. Their flagship product, Comega, is a unique marine oil rich in both Cetoleic acid (Omega-11) and Omega-3 fatty acids, designed for applications in human nutrition and health. The company emphasizes a sea-to-capsule approach, ensuring full traceability and minimal environmental impact through its integrated production facilities in Norway. Grøntvedt Biotech focuses on the health benefits of Cetoleic acid, which research suggests can stimulate the body's internal production of EPA and DHA. By maintaining control over the entire value chain, the company provides sustainable and science-backed ingredients for the global nutraceutical and functional food markets.